Clinical trialNAUnknown
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
Prospective Cohort Study Comparing Robotic and Open Surgery for Pancreatic Cancer
- Outcome
- Outcome unknown
- Phase
- NA
- Status
- Unknown
- Study type
- Interventional
- Start
- 1 March 2019
- Expected end
- December 2024
- Enrollment
- 300 participants
- Sites
- 1
- Primary outcomes
- 1 year overall survival rate; 3 years overall survival rate
- Sponsor
- Other
- Results posted
- No
- Last update
- 9 April 2021
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to determine whether robotic surgery has limitations in terms of patient age, tumor size, location, and vascular relationship when compared to open surgery for pancreatic cancer. Whether robotic surgery has advantages over intraoperative bleeding, operative time, postoperative complications (bleeding, infection, pancreatic fistula) and postoperative hospital stays compared to open surgery.And the differences in lymph nodes harvest and postoperative survival between two groups.